Lung cancer : journal of the International Association for the Study of Lung Cancer
-
Multicenter Study
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy.
To investigate the efficacy and safety of nivolumab in Korean patients with stage IIIB/IV or recurrent non-small-cell lung cancer (NSCLC) who failed platinum-based chemotherapy. ⋯ The efficacy and safety of nivolumab in Korean patients with advanced or recurrent squamous or non-squamous NSCLC are consistent with previous reports.